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Abstract
Background: Recommendations about scaling up HIV testing and counseling highlight the need to provide key services
and to protect clients’ rights, but it is unclear to what extent different modes of testing differ in this respect. This paper
examines whether practices regarding consent, confidentiality, and referral vary depending on whether testing is provided
through voluntary counseling and testing (VCT) or provider-initiated testing.
Methods and Findings: The MATCH (Multi-Country African Testing and Counseling for HIV) study was carried out in Burkina
Faso, Kenya, Malawi, and Uganda. Surveys were conducted at selected facilities. We defined eight outcome measures
related to pre- and post-test counseling, consent, confidentiality, satisfactory interactions with providers, and (for HIV-
positive respondents) referral for care. These were compared across three types of facilities: integrated facilities, where
testing is provided along with medical care; stand-alone VCT facilities; and prevention of mother-to-child transmission
(PMTCT) facilities, where testing is part of PMTCT services. Tests of bivariate associations and modified Poisson regression
were used to assess significance and estimate the unadjusted and adjusted associations between modes of testing and
outcome measures. In total, 2,116 respondents tested in 2007 or later reported on their testing experience. High
percentages of clients across countries and modes of testing reported receiving recommended services and being satisfied.
In the unadjusted analyses, integrated testers were less likely to meet with a counselor before testing (83% compared with
95% of VCT testers; p,0.001), but those who had a pre-test meeting were more likely to have completed consent
procedures (89% compared with 83% among VCT testers; p,0.001) and pre-test counseling (78% compared with 73%
among VCT testers; p = 0.015). Both integrated and PMTCT testers were more likely to receive complete post-test counseling
than were VCT testers (59% among both PMTCT and integrated testers compared with 36% among VCT testers; p,0.001).
Adjusted analyses by country show few significant differences by mode of testing: only lower satisfaction among integrated
testers in Burkina Faso and Uganda, and lower frequency of referral among PMTCT testers in Malawi. Adjusted analyses of
pooled data across countries show a higher likelihood of pre-test meeting for those testing at VCT facilities (adjusted
prevalence ratio: 1.22, 95% CI: 1.07–1.38) and higher satisfaction for stand-alone VCT facilities (adjusted prevalence ratio:
1.15; 95% CI: 1.06–1.25), compared to integrated testing, but no other associations were statistically significant.
Conclusions: Overall, in this study most respondents reported favorable outcomes for consent, confidentiality, and referral.
Provider-initiated ways of delivering testing and counseling do not appear to be associated with less favorable outcomes for
clients than traditional, client-initiated VCT, suggesting that testing can be scaled up through multiple modes without
detriment to clients’ rights.
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Introduction
Since HIV tests became available in the mid-1980s, concerns
about human rights have led to heated discussions among those
promoting wider testing and those who fear the social
consequences of positive diagnoses. In the early years of the
epidemic, a degree of ‘‘exceptionalism’’ characterized policies
around HIV, whereby public health measures that were
considered normal for other diseases, including routine testing,
were deemed unacceptable in the case of HIV, because of the
potential for stigma and discrimination [1]. Proponents of wider
testing maintained that traditional modes of voluntary counseling
and testing (VCT) could not sufficiently expand access to
treatment and prevention [2], but many human rights advocates
were reluctant to endorse the routinization of testing or its
expansion at health facilities. They argued that the potential
benefits did not outweigh the risks, that only client-initiated VCT
was acceptable, and that careful scrutiny of consent procedures
and practices around confidentiality was necessary [3–6]. Despite
the wider availability of treatment, there are continuing concerns
about expanding testing if consent, confidentiality, and proper
care cannot be guaranteed [1,3].
Until recently, the evidence to inform debates around HIV
testing was patchy, in part because of the lack of unified criteria to
measure outcomes, particularly in sub-Saharan Africa. In addi-
tion, studies that examined the shift from client- to provider-
initiated testing tended to focus on acceptance rates rather than on
actual testing experience [7]. There have not been systematic
examinations of differences in outcomes for VCT compared to
provider-initiated testing and counseling (PITC).
In the past few years, growing interest in monitoring HIV
testing has led to the formulation of guidelines to ensure that
practices around informed consent, confidentiality, and care
respect the rights of clients. In 2007, the World Health
Organization published a guidance document on PITC, shortly
after the US Centers for Disease Control and Prevention had
developed their own guidelines, and in 2009, European countries
formulated guidelines to define minimum standards of what
should be provided everywhere [8–10] (see also the more recent
summaries [11,12]). Despite some variations, these international
guidelines represent a useful basis to define a set of outcomes that
are measurable across settings.
The MATCH (Multi-Country African Testing and Counseling
for HIV) study was designed to conduct systematic comparisons
across countries of different ways of providing HIV testing
(referred to here as modes of testing). Its overall goals are to
investigate the uptake of testing, to analyze differences in the
experience of testing across countries and modes of testing, and to
assess the implications of these results for policies designed to
increase knowledge of HIV status and referral to care. The project
formulated a number of specific aims regarding variations in
services around testing, in motivations to test, and in the
experience of testing and its consequences, as reported by clients
and by providers. Different sorts of data were collected, ranging
from large surveys of clients using precoded responses (used in this
analysis) to qualitative data transcribed from semi-structured
interviews with key informants (not used in this analysis). Analyses
of MATCH data focus on particular subsets of the data, for
example, those pertaining to attitudes towards testing, the extent of
stigma, or the frequency of disclosure of HIV status. In this
analysis, we focus on services related to testing and examine the
extent to which consent, confidentiality, and referral to care vary
across modes of testing, namely VCT and PITC.
MATCH was conducted in four countries—Burkina Faso,
Kenya, Malawi, and Uganda—that exemplify different approach-
es to the provision of services. In all four countries, multiple
government- and donor-supported initiatives have been imple-
mented, and, increasingly, testing is conducted at health facilities.
But testing practices reflect the countries’ different histories with
HIV testing and foreign aid, and there are differences in the pace
of increase (somewhat slower in Burkina Faso), in the scale of the
resources invested (larger in Kenya and Uganda), in the role of
VCT (which still represents an important mode of provision in
Burkina Faso and Uganda), and in the relative roles of
governments and nongovernment organizations. All four countries
face similar challenges with the expansion of testing: insufficient
resources, infrastructure, and adequately trained staff; limited
public awareness about the risks of HIV; and difficulties with
referral and follow-up. But while fears of coercion and breaches of
confidentiality are frequently invoked in the literature, it is unclear
whether these differ depending on how testing is provided, and
how clients feel regarding their experiences with different modes of
testing.
This paper analyzes respondents’ reports regarding consent,
confidentiality, and referral, to assess whether these outcomes
differ systematically by mode of testing. Specifically, we assess
whether eight outcome measures related to the completeness and
quality of services—including the adequacy of pre- and post-test
counseling, clients’ consent to test, confidentiality, satisfactory
interactions with providers, and referral for those HIV positive—
differ between provider-initiated and client-initiated modes of
testing. The null hypothesis, that there are no significant
differences, would suggest that inadequate outcomes are not more
likely when testing is scaled up at health facilities.
Methods
Ethics Statement
The study was approved by the Ethics Review Committee of the
World Health Organization and by an Institutional Review Board
(IRB) in each of the four countries (Burkina Faso’s Comite´
d’Ethique pour la Recherche en Sante´ of the Ministries of Health
and Higher Education, Kenyatta National Hospital’s IRB in
Kenya, the National Health Sciences Research Committee of the
Ministry of Health and Population in Malawi, and the IRB of
Makerere University and the National Council for Science and
Technology in Uganda). Informed consent was obtained from all
respondents who were invited to participate in the study. In
Burkina Faso and Uganda, consent was in writing for virtually all
respondents, except for a few illiterate respondents, who provided
a thumbprint; in Malawi and Kenya, a greater proportion of
respondents gave oral consent, consistent with local practices and,
in the case of Malawi, because of higher illiteracy. Because the
proportion of oral consent was relatively high in Kenya (24%),
special permission to use the data from those interviews was
obtained from the IRB. No identifying information was collected
as part of the study dataset.
Study Design and Sample
The core component of the MATCH study is a client survey,
conducted in 2008–2009 at health facilities. It was designed to
represent users of health facilities in the capital city and one
province in each country, and to include individuals who had
tested and others who had not tested for HIV. In each country, the
research team, which comprised individuals knowledgeable about
HIV testing, drew up a list of health facilities or services within
HIV Testing and the 3Cs in Africa
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large facilities that provided HIV testing, and facilities or services
known not to provide HIV testing. The list of facilities for testers
included the major providers of testing services and different types
of facilities, namely, stand-alone facilities for VCT and integrated
facilities where testing was provided along with prenatal care,
tuberculosis treatment, or general medical care. Non-testers were
recruited at medical facilities or services where HIV testing was
not provided. Testing status was ascertained for all respondents.
Other components of the MATCH study, not incorporated into
this analysis, include smaller surveys of clients tested at home or
during campaigns, interviews with providers, and semi-structured
interviews with selected clients and providers.
About 20 facilities or services within larger facilities were
selected for inclusion in each country. Adult clients (aged 18 y and
over) who were present at the selected facilities on the appointed
days were invited to participate in the study. All respondents who
agreed to discuss their experience with testing or not testing for
HIV were included. Response rates are estimated at 80% in
Burkina Faso and 90% in Malawi and Uganda; the figure for
Kenya is considerably lower, at about one-half, reflecting the
difficult political situation prevailing in 2008, which translated into
poor security, reluctance to participate, and cancelling or aborting
of interviews.
The instrument used in the client survey included closed- and
open-ended questions about socio-demographic information;
attitudes towards HIV testing and counseling; testing status; for
those previously tested, a checklist on services received during pre-
and post-test meetings and follow-up care; and interactions with
providers and experiences before, during, and after testing,
including disclosure and stigma. The interview was piloted in
the four countries and revised in light of field experience to ensure
that the questions were understood and the sequence of questions
was adequate. Interviews lasted approximately 30 min.
A total of 3,659 respondents were interviewed at the selected
facilities in the four countries. Because we were interested in recent
testing experience across different modes of testing, this analysis
focuses on respondents who reported testing at different sorts of
facilities in the 2 y preceding the survey. We excluded non-testers
(1,088); testers who reported testing before 2007 or who were
missing information on test date or testing status (385); those
missing data on place of test or whose place of test could not be
categorized, for example, if they tested abroad (34); and those
missing information on covariates (36). Thus, the analysis includes
2,116 respondents tested at different types of facilities in 2007 or
later. Each outcome was analyzed using a complete case method.
Denominators are not the same for all outcome measures, for
example, respondents who did not meet with a counselor before
their test were not eligible to answer questions about the quality of
pre-test counseling. The final sample values are found in Table 1.
The analysis is stratified by country, because differences in policy
environments and in the implementation of HIV testing made it
plausible that there would be different associations in the four
countries between test modes and the outcome measures in which
we were interested.
This analysis is designed to assess the extent to which
respondents’ experiences with testing are consistent with prevalent
standards for the quality and completeness of the services to be
provided along with HIV testing. We draw on data collected in
response to questions and checklists regarding respondents’ testing
experience, including the information, advice, and referral that
were provided during pre- and post-test counseling, interaction
with providers, and the extent to which clients’ rights were
protected by practices regarding consent and confidentiality. We
assess whether there are differences in these responses for clients
tested at different types of testing facilities, adjusting for
respondents’ socioeconomic characteristics and for the clustering
of responses in interview facilities.
Outcome Measures
Primary outcomes in this study included eight measures of the
quality and completeness of the testing process for each
respondent. Unified guidelines for testing were not available for
the four countries at the time the study was designed, but we drew
on the documents issued by the World Health Organization and
the US Centers for Disease Control and Prevention [8,9] to define
the elements that were generally thought to ensure adequate care
and to protect individuals’ rights during and after HIV testing.
The ‘‘3 Cs’’ framework refers to consent, confidentiality, and
counseling as essential elements in HIV testing [13]. In view of
discussions regarding how much pre-test counseling is necessary,
and the need to tailor post-test counseling to the test results
[8,9,14], we examined the adequacy of pre- and post-test
counseling separately. Thus, pre- and post-test counseling,
consent, and confidentiality are the first four outcomes. We used
clients’ reports on their interactions with providers—whether they
thought the information provided was sufficient, whether they
were well treated, and whether they found the meeting useful—to
create a fifth outcome measure that we referred to as satisfaction.
The sixth outcome measure, referral, captures the extent to which
testing was linked to further care for HIV-positive respondents. In
addition, because pre-test measures depend on having had a pre-
test meeting and post-test measures on receiving results, we also
analyzed the likelihood of these two additional outcome measures
where appropriate, for a total of eight outcome measures.
We used respondents’ responses to specific questions in the
interview to create an index for each of these outcome measures.
Because we wanted to assess whether each required element was
present, we gave equal importance to the items that defined each
index, and coded the index as complete if all items were present,
and as incomplete if any was absent. The outcome measures and
the individual items that make up each index are summarized in
Box 1.
Independent Variables
The key independent variable used is the mode of testing. The
different types of testing facilities were grouped into three modes of
testing: (1) integrated testing, which included hospitals and medical
facilities where provider-initiated and client-initiated testing were
both provided, along with medical services; (2) stand-alone VCT;
(3) prevention of mother-to-child transmission (PMTCT) testing,
which included antenatal clinics and other facilities offering care to
pregnant women; additionally, all women who reported testing in
integrated testing facilities because of pregnancy were coded as
PMTCT testers.
Other covariates that may have influenced clients’ experiences
of testing and were adjusted for in the analyses included age,
education, and wealth. Age was self-reported and measured in
years. Education was specified as no schooling, incomplete or
completed primary education, or some secondary education. We
developed a country-specific wealth index using principal compo-
nents analysis. The wealth index methodology is based on the
Filmer-Pritchett wealth score methodology developed for Demo-
graphic and Health Surveys [15], which incorporates dichotomous
variables into a wealth score using factor analysis. This method has
been widely used in international health surveys and has been
established as a reliable proxy for household wealth. Respondents’
household assets (television, electric or gas stove, telephone, land,
animals) and amenities (tap water, flush toilet, electricity) were
HIV Testing and the 3Cs in Africa
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converted into z-scores, and factor loadings for a single wealth
factor were calculated. Values of the indicator variables were
multiplied by the factor loadings to obtain a wealth score for each
respondent. Within each country, respondents were grouped into
quartiles by wealth score.
Analysis Plan
We estimated the unadjusted and adjusted effects of mode of
testing on the eight outcome measures. The effect of mode of
testing on referral to subsequent care is estimated for HIV-
positive respondents only. Unadjusted associations were tested
using chi-squared tests, and Fisher’s exact tests of significance
were also used in analyses with cell sizes of five or fewer
respondents. In many cases, more than 10% of respondents in
each group had tested for HIV, so odds ratios estimated using
logistic regression analysis would not provide a reasonable
estimate of the relative prevalence of testing. Consequently, to
estimate adjusted associations between mode of testing and index
scores we used a modified Poisson regression analysis with robust
standard errors [16]. We report 95% confidence intervals for all
parameters and exact p-values from Wald tests of significance for
all tests where p$0.001. Given the number of comparisons, our
analyses also adjusted for false discovery rate using the Benjamini,
Krieger, and Yekutieli step-up adjustment method [17], as
implemented using the smileplot add-on to Stata 10 [18] and an
unadjusted p-value of 0.05.
All regression analyses estimated the effect of mode of testing,
and we compared VCT and PMTCT to integrated testing as the
reference category. Regression analyses were adjusted for country,
using a fixed effect (fixed effect parameters and constants not
shown), and standard errors were adjusted for clustering of
responses at the interview facility, using a generalized estimating
equation. All analyses were completed in Stata, release SE 10.1
[19]. This report adheres to STROBE guidelines (see Text S1).
Results
The distribution of respondents by testing mode differs across
countries. More respondents tested at stand-alone VCT sites than
at integrated sites in Burkina Faso (55% [293/537] and 26%
[138/537], respectively) and Uganda (47% [315/664] and 38%
[255/664]), while more tested at integrated sites than at stand-
alone VCT sites in Malawi (65% [348/533] and 8% [43/533],
respectively) and Kenya (70% [268/382] and 9% [34/382]).
PMTCT testers ranged from 14% (94/664) in Uganda to 27%
(142/533) in Malawi. (Detailed frequencies of respondents’ age,
sex, educational attainment, and wealth score quartiles, by country
and mode of testing, are presented in Table S1.)
Table 1 presents the frequencies of respondents’ reports on the
eight outcome measures across all countries and for each country.
Across all countries, respondents in integrated testing were less
likely to meet with a counselor before their HIV test (83%
compared with 95% of VCT testers; p,0.001), but those who did
meet with a counselor were more likely to have completed consent
procedures (89% compared with 83% among VCT testers;
p,0.001) and pre-test counseling (78% compared with 73%
among VCT testers; p = 0.015). Both integrated and PMTCT
testers were more likely to receive complete post-test counseling
than were VCT testers (59% among both PMTCT and integrated
testers compared with 36% among VCT testers; p,0.001).
Differences among the three groups in proportion referred to
care, proportion satisfied with their post-test counseling, and
proportion believing that confidentiality had been ensured were
not significant.
Examining the unadjusted associations between testing mode
and outcome measures by country reveals some notable
differences, as shown in Table 1. In Burkina Faso, integrated
testers were significantly less likely to meet with a counselor
before their test (67% compared with 96% among VCT testers;
p,0.001), to have a complete pre-test index (46% compared
with 62% among VCT testers; p,0.001), and to be satisfied with
post-test counseling (62% compared with 77% of VCT testers
and 77% of PMTCT testers). In Uganda, integrated testers were
less likely to meet with a counselor (73% compared with 94%
among VCT testers; p,0.001), to have complete pre-test
counseling (67% compared with 81% among VCT testers and
77% among PMTCT testers; p = 0.003), to have complete post-
test counseling (46% compared with 52% among VCT testers
and 67% among PMTCT testers; p = 0.003), and to be satisfied
with post-test counseling (65% compared with 80% among VCT
testers and 69% among PMTCT testers; p,0.001). In Malawi,
VCT testers were less likely to receive full post-test counseling
than PMTCT or integrated testers (54% of VCT testers
compared with 71% of integrated testers and 75% of PMTCT
testers; p = 0.023). In Kenya there were no significant differences
across testing modes.
Table 2 presents the effects of mode of testing on the eight
outcome measures, after adjustment for respondent age, sex,
educational attainment, and wealth. In Burkina Faso, satisfaction
with post-test counseling remained significantly higher among
VCT testers than among integrated testers; the adjusted
prevalence ratio (APR) comparing VCT testers to integrated
testers was 1.28 (95% CI: 1.10–1.48). In Uganda, respondents
testing in stand-alone VCT sites were significantly more likely to
meet with a counselor (APR: 1.25; 95% CI: 1.04–1.51), to have
completed confidentiality procedures (APR: 1.13; 95% CI: 1.04–
1.23), and to be satisfied with their post-test counseling
experience (APR: 1.23; 95% CI: 1.10–1.37), while HIV-positive
PMTCT testers were significantly less likely to receive referrals
for additional care (APR: 0.71, 95% CI: 0.57–0.89). In Malawi,
respondents testing in stand-alone VCT sites were significantly
more likely to meet with a counselor before testing (APR: 1.11;
95% CI: 1.05–1.18).
Analyses of the pooled data across countries show a higher
likelihood of a pre-test meeting for VCT (APR: 1.22; 95% CI:
1.07–1.38) compared to integrated testing, and higher satisfaction
for VCT compared to integrated testing (APR: 1.15; 95% CI:
1.06–1.25). Other differences were not statistically significant.
Discussion
First, a major result of this analysis is that across all countries
and modes of testing, high percentages of clients reported having
received the services around testing that are considered important
in most guidelines. As shown in Table 1, across the four
countries, 89% reported having a pre-test meeting, and more
than 75% reported a complete pre-test index. Consent, confi-
dentiality, and overall satisfaction indices were high, at 86%,
79%, and 81%, respectively. Provision of post-test services was
generally lower: though 99% received their results, just over half
reported a complete post-test index, and 71% of HIV-positive
respondents reported a complete referral index. This suggests that
there is still a good deal of room for improvement to provide
advice and referral after HIV testing, but that services around
testing do not appear to be associated with major breaches of
autonomy or privacy. When we compared reports by HIV-
positive and HIV-negative respondents, we found them to be
similar, and where they differed, HIV-positive respondents
HIV Testing and the 3Cs in Africa
PLOS Medicine | www.plosmedicine.org 4 October 2012 | Volume 9 | Issue 10 | e1001329
reported more favorably on the services received, which does not
support the notion that HIV-positive individuals receive worse
services due to stigma.
A second major result of this analysis is that there were some
significant associations between outcome measures and modes of
testing, but differences across modes of testing were not consistent
with the notion that one mode of testing performs better than the
others. As shown in Tables 1 and 2, unadjusted analyses indicate
somewhat more favorable reports at integrated testing sites on a
few outcome measures, while analyses adjusting for covariates and
clustering of facilities show slightly higher likelihood of better
outcomes for VCT. In general, the results do not support the
notion that testing at integrated health facilities functions less
adequately than at stand-alone VCT sites.
Table 1. Percent respondents reporting on outcome measures of HIV testing, by country and mode of testing.
Country Outcome Measure
Integrated
(Percent)
VCT
(Percent)
PMTCT
(Percent) Total (n)
Total
(Percent Yes) x2(2) p-Value
All countries Pre-test: meet with counselor 83.3 95.3 92.3 1,875 89 66.18 ,0.001
Pre-test index: all items 78.6 73.1 72.3 1,410 75.4 8.38 0.015
Consent index: all items 89.7 83.4 82.9 1,611 86.1 16.51 ,0.001b
Post-test: received results 98.6 100 99 1,997 99.1 9.04 0.011
Post-test index: all items 58.7 35.8 59 1,015 51.5 90.25 ,0.001
Confidentiality index: all items 81.6 77 77.6 1,451 79.2 5.34 0.069
Referral indexa: all items 73.7 66.2 63.3 393 70.6 4.52 0.105
Satisfaction index: all items 80.2 79.9 83 1,647 80.7 1.78 0.411
Burkina Faso Pre-test: meet with counselor 67.4 96.3 96.2 538 88.8 86.24 ,0.001b
Pre-test index: all items 45.7 62.4 40.2 476 54.4 18.43 ,0.001b
Consent index: all items 77.2 74.8 83.3 476 77.1 3.07 0.215
Post-test: received results 95.6 100 100 537 98.9 17.72 ,0.001b
Post-test index: all items 7.8 15.1 14.2 525 13.1 4.28 0.118
Confidentiality index: all items 75 77.4 64.4 463 74.1 6.56 0.038
Referral indexa: all items 63.8 50.8 83.3 114 57.9 3.52 0.172
Satisfaction index: all items 62.1 77.0 77.1 516 73.4 10.79 0.005b
Kenya Pre-test: meet with counselor 97 97 92.4 376 96 3.39 0.183
Pre-test index: all items 82.8 75 82.2 361 82 1.18 0.555
Consent index: all items 95.3 93.8 90.4 361 94.2 2.50 0.286
Post-test: received results 99.2 100 100 376 92.4 0.86 0.649
Post-test index: all items 79.1 68.8 82.1 363 78.8 2.44 0.296
Confidentiality index: all items 78.8 72.7 74 356 77.2 1.17 0.557
Referral indexa: all items 81.4 77.8 87.5 130 81.5 0.27 0.872
Satisfaction index: all items 83.1 87.5 88.6 366 84.7 1.60 0.448
Malawi Pre-test: meet with counselor 87 97.7 91.4 529 89 5.49 0.064
Pre-test index: all items 92.1 90.5 89 471 91.1 1.06 0.588
Consent index: all items 94.4 88.1 88.2 471 92.1 5.76 0.056
Post-test: received results 99.4 100 99.3 524 93.3 0.30 0.860
Post-test index: all items 71.2 53.5 75.2 517 70.8 7.53 0.023b
Confidentiality index: all items 94.9 85.7 92 462 93.3 5.43 0.066
Referral indexa: all items 66.2 57.1 56.3 175 64 1.26 0.533
Satisfaction index: all items 95.3 90.7 93.5 520 94.4 1.84 0.398
Uganda Pre-test: meet with counselor 72.7 93.9 89.4 664 85.1 51.97 ,0.001b
Pre-test index: all items 67.2 80.8 77.4 562 75.8 11.62 0.003b
Consent index: all items 80.6 89.8 67.5 563 83.5 25.02 ,0.001b
Post-test: received results 98.2 100 96.6 578 98.8 7.23 0.027b
Post-test index: all items 45.9 52.1 67.4 565 52 11.48 0.003b
Confidentiality index: all items 67.0 75.8 75.3 552 72.8 4.61 0.100
Referral indexa: all items 86.0 78.4 57.1 138 79 5.52 0.063
Satisfaction index: all items 65.0 80.4 68.5 640 73 17.29 ,0.001b
aIncludes only HIV-positive respondents.
bRemains significantly less than 0.05 after correction for false discovery rate.
doi:10.1371/journal.pmed.1001329.t001
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Taken together, these results suggest that the rights of clients,
particularly regarding informed consent and confidentiality, can
be protected even as testing is scaled up at health facilities. Some
studies have suggested that consent and confidentiality may be
jeopardized by inadequate facilities and procedures, poor coun-
seling, or the power differential between providers and patients
[20–27], while other studies have documented high acceptability
and improved referral, with no reduction in the utilization of
health services when testing is routinized [7,28–30]. The results of
this analysis are consistent with studies showing that routine testing
is compatible with ethical practices [31,32], and this should
provide some reassurance about the possibility of scaling up HIV
testing through PITC without compromising individual protec-
tion.
The association of VCT with more positive outcome measures
than integrated or PMTCT testing in Uganda—specifically pre-
and post-test counseling, receiving results, and satisfaction—can
be attributed to the role of nongovernment organizations, which
mobilized early on, when VCT was the only mode of provision, to
encourage testing, increase awareness, and fight stigma and
discrimination. The less favorable outcomes for pre- and post-test
counseling in Burkina Faso may be attributable to the more recent
initiation of PITC in the country, which had, for a long time,
relied on VCT provided via freestanding facilities and national
campaigns. PITC facilities are comparatively less resourced in
Burkina Faso, and the guidelines in place at the time of the survey
did not recommend all of the post-test items that we included in
our indices. Instead, the guidelines in Burkina Faso referred to
explaining the meaning of results, providing advice on prevention,
and answering questions. When measured against more demand-
ing standards, testing services fell short. These results underscore
the need to clarify and harmonize guidelines on testing and
counseling and to support their implementation.
The data were collected in 2008–2009, at an important time for
the scale-up of HIV testing programs. In the countries where the
study was conducted, as well as globally, 2006–2007 was a turning
point for the increased availability of treatment, the formulation of
guidelines, and the implementation of programs to increase
knowledge of HIV status. The results reflect the scale-up of these
efforts and are likely indicative of subsequent trends.
The generally favorable outcomes that are documented in this
study suggest that it is possible to expand client- and provider-
initiated testing while protecting patients’ rights. This should not
be surprising. The standards defined by guidelines on testing, such
as informing clients, obtaining consent, and providing informa-
tion, are not especially exacting, and can be achieved in most
settings. Other studies, such as in the United States [33,34] and in
Egypt [35], have reported similarly high levels of service provision
ad satisfaction.
It is possible that the high values we found in reported measures
of satisfaction result in part from a contrast with clients’ general
experience with other health services, which tends to be
suboptimal, so that, by comparison, the quality HIV testing
services appears to be satisfactory. It is also possible that because
respondents were interviewed at health facilities, they may have
felt that they should not appear ungrateful for the services they
receive, and hence may have given more favorable answers. In
order to assess the extent of such social desirability bias, we
conducted a sensitivity analysis comparing outcomes among
respondents who tested at facilities where interviews were
conducted and those who reported testing at facilities not included
in the MATCH project. We found that outcomes among
respondents tested at MATCH facilities tend to be similar to, or
less positive than, those who did not test at MATCH facilities,
suggesting that the facility environment did not substantially
influence respondents’ reports on the care they received.
Other studies in Kenya and Malawi have found that counseling
may be neglected when testing is scaled up, and that clients may
perceive testing as compulsory [36,37]. Qualitative data such as
were used in these studies are important complements to surveys.
Box 1. Outcome Measures Regarding Pre- and
Post-Test Counseling and Referral
Indices of Pre- and Post-Test Counseling and
Referral*
1. Pre-test counseling index
Whether the provider:
N Explained how HIV is transmitted
N Explained the meaning of positive and negative results
N Gave time to ask questions
2. Post-test counseling index
Whether the provider:
N Explained the meaning of the results
N Gave advice on prevention
N Advised discussing test results with significant others
N Advised partner referral
N Gave time to ask questions
3. Consent index
Whether the provider:
N Asked if respondent agreed to test
N Explained that respondent had a choice to accept or
refuse
4. Confidentiality index
N Whether provider explained that results would not be
shared
N Whether respondent believed results had been protect-
ed
5. Satisfaction with post-test counseling index
Whether respondent:
N Thought s/he received sufficient information
N Thought s/he was well treated
N Thought the meeting was useful
6. Referral index (only for HIV-positive individuals)
Whether respondent:
N Was referred for care during post-test counseling
N Was ever prescribed medications
Additional Outcome Measures
7. Pre-test meeting
Whether the respondent had a pre-test meeting
8. Post-test results received
Whether the respondent received results in post-test
meeting
*Based on the questions as phrased in the questionnaire.
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Table 2. Prevalence ratios for outcome measures, by country and mode of testing.
Outcome Measure Adjusted Prevalence Ratio (95% CI)
All Countries Burkina Faso Kenya Malawi Uganda
Pre-test meeting
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.22a 1.45 0.90 1.11a 1.25
(1.07–1.38) (0.94–2.22) (0.72–1.12) (1.05–1.18) (1.04–1.51)
PMTCT 1.09 1.41 0.97 1.03 1.17
(1.00–1.20) (0.93–2.13) (0.85–1.10) (0.96–1.09) (0.93–1.47)
Pre-test index complete
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.15 1.34 0.90 0.97 1.18
(0.99–1.33) (0.86–2.10) (0.72–1.12) (0.85–1.10) (0.97–1.44)
PMTCT 0.98 0.88 0.97 0.96 1.15
(0.88–1.09) (0.59–1.31) (0.85–1.10) (0.87–1.06) (0.91–1.45)
Consent index complete
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.03 1.01 1.00 0.94 1.1
(0.95–1.12) (0.82–1.24) (0.93–1.08) (0.88–1.01) (0.96–1.27)
PMTCT 0.95 1.08 0.94 0.93 0.86
(0.89–1.02) (0.89–1.31) (0.82–1.09) (0.87–1.00) (0.66–1.11)
Post-test results received
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.02 1.05 1.00 1.01 1.02
(1.00–1.04) (0.99–1.10) (1.00–1.01) (1.00–1.03) (1.00–1.04)
PMTCT 1.00 1.04 1.00 0.99 0.98
(0.99–1.01) (0.99–1.08) (0.99–1.00) (0.98–1.01) (0.95–1.02)
Post-test index complete
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.00 1.93 0.91 0.78 1.05
(0.83–1.20) (0.90–4.10) (0.69–1.21) (0.59–1.03) (0.86–1.28)
PMTCT 1.09 1.87 1.04 1.00 1.40
(0.94–1.27) (0.83–4.24) (0.91–1.20) (0.85–1.17) (1.01–1.94)
Confidentiality index complete
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.04 1.02 0.99 0.91 1.13a
(0.97–1.11) (0.90–1.15) (0.82–1.18) (0.79–1.05) (1.04–1.23)
PMTCT 0.97 0.88 0.94 0.97 1.14
(0.90–1.06) (0.76–1.02) (0.71–1.26) (0.91–1.03) (0.96–1.36)
Referral index completeb
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 0.87 0.76 0.90 0.84 0.91
(0.74–1.02) (0.50–1.16) (0.78–1.04) (0.57–1.22) (0.78–1.07)
PMTCT 0.89 1.56 0.88 0.89 0.71a
(0.73–1.08) (0.87–2.78) (0.64–1.20) (0.62–1.26) (0.57–0.89)
Satisfaction index complete
Integrated testing 1.00 1.00 1.00 1.00 1.00
Stand-alone VCT 1.15a 1.28a 1.02 0.97 1.23a
(1.06–1.25) (1.10–1.48) (0.87–1.21) (0.88–1.06) (1.10–1.37)
PMTCT 1.05 1.19 1.06 0.97 1.07
(0.98–1.13) (1.03–1.38) (0.92–1.22) (0.92–1.03) (0.80–1.43)
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They provide insights into potential gaps in the functioning of
services, highlighting research questions regarding counseling and
consent for further investigation and suggesting areas for
improvement. Analyses are underway on the texts transcribed
from responses to open-ended questions in the MATCH survey,
and from the semi-structured interviews carried out in parallel
with the survey. The texts provide a complementary way to assess
clients’ views, and the analyses should yield more detailed insights
into the reasons for clients’ positive or negative evaluations of their
testing experiences.
There are limitations to this study, including the fact that the
outcome measures may not account for important social, cultural,
and health service variations. Our measures of referral and
medication use do not include specific details, and hence provide
only a rough measure of referral. In addition, our analysis
distinguishes modes of testing as discussed in the literature, and
compares VCT and PITC (including integrated and PMTCT
testing), but the reality of services on the ground is complex, and
the boundaries among types of testing facilities are not always
strict. It is also possible that the lack of significant associations
between testing mode and outcomes at the level of individual
countries reflects the smaller numbers of respondents in some of
the categories of testing, and that larger samples may have been
able to detect more associations.
A further limitation comes from using a sample of convenience,
based on systematic rather than random selection, and hence not
necessarily representative. This strategy was deemed to be
appropriate, since the goal was to compare testing experiences
across modes of testing. MATCH respondents are more urban,
educated, and wealthy than respondents to national surveys—
except in Malawi, where they are similar [38–41]. This is not
surprising, since users of health facilities tend to have higher
socioeconomic status than the general population. Thus, there are
reasons to believe that these results are not gross overestimates and
that they reflect the reality of testing in the selected areas.
A strength of this study is that it used the same outcome
measures and methodology across sites. Hence, results can be
compared across countries to address policy questions about
modes of testing. While there are considerable differences, both
within and among countries, in the structural factors that define
health services and accessibility and the meanings attached to
testing, the motivations behind it, and its consequences, there is a
degree of consistency in the results that likely reflects the state of
services around testing in these different settings.
Conclusion
Despite variations within and across countries in the outcome
measures for pre- and post-test counseling, consent, confidential-
ity, referral, and satisfaction, respondents’ reports indicate that the
frequencies of positive responses on these measures are generally
high, suggesting that overall, people testing for HIV do not appear
to experience adverse outcomes such as coercion or breaches of
confidentiality, and that the majority of people who are tested are
satisfied with the services they receive.
The fact that we found few consistent associations between
mode of testing and outcome measures is also encouraging.
Provider-initiated modes of testing (integrated medical testing and
PMTCT testing) were not more likely to be associated with less
favorable outcome measures than VCT. These results should
provide some reassurance that the efforts to provide HIV testing in
different countries through different approaches can help improve
knowledge of HIV status and referral to appropriate care.
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Editors’ Summary
Background. In 2007, World Health Organization (WHO)
and the Joint United Nations Programme on HIV/AIDS
(UNAIDS) issued a joint guidance document on ‘‘provider-
initiated’’ HIV testing and counseling. They noted that
previous testing strategies that relied on ‘‘client-initiated’’
testing (also referred to as VCT, for voluntary counseling and
testing) had failed to reach enough people, both in high-
income and resource-constrained countries—in Africa, for
example, at that time, just 12% of men and 10% of women
had ever been tested. They argued that many opportunities
to diagnose and counsel people that visit health facilities for
other reasons are being missed, and that provider-initiated
HIV testing and counseling can help expand access to HIV
treatment, care, and support. They made it clear, however,
that mandatory testing is not acceptable. All provider-
initiated testing must therefore give individuals the option to
not be tested. In addition, the guidelines stressed that all
testing must continue to observe ‘‘the three Cs’’ (informed
consent, counseling, and confidentiality) and be accompa-
nied by an ‘‘enabling environment’’ including the availability
of antiretroviral therapy, prevention and support services,
and a supportive social, policy, and legal framework. A
number of advocates have subsequently criticized the
guidelines for failing to recognize that health-care services
and staff in some countries do not always observe the three
Cs. Critics have also questioned the appropriateness of the
strategy for settings where antiretroviral therapy is not
always available or where stigma and discrimination remain
widespread.
Why Was This Study Done? To inform the debate
surrounding scale-up of HIV testing in general and provid-
er-initiated testing in particular with data on ‘‘real-life’’
testing, researchers have since carried out a number of
studies. One of them, called MATCH (for Multi-Country
African Testing and Counseling for HIV), was designed to
allow systematic comparisons across African countries of
different ways of HIV testing. Its goal was to investigate the
uptake of testing, to analyze differences in the experience of
testing across countries and modes of testing, and to use the
results to devise better strategies to increase knowledge of
HIV status and referral to care. MATCH used different means
to collect information, including surveys and interviews.
People from Burkina Faso, Kenya, Malawi, and Uganda
participated. Some had undergone HIV testing, others had
not. This study used a subset of the survey data collected for
the MATCH study and asked whether there were systematic
differences depending on the type of testing people had
experienced.
What Did the Researchers Do and Find? The data the
researchers used were from 2,116 people who had undergone
testing in the two previous years at different facilities in the four
countries. The different facilities were grouped into three
‘‘modes’’ of testing: VCT-only testing, integrated testing (which
included hospitals and other medical facilities where provider-
initiated and client-initiated testing were both available, along
with other medical services), and prevention of mother-to-child
transmission (PMTCT) testing at medical facilities offering
services to pregnant women. Analyzing the survey responses,
the researchers categorized them as related to eight different
‘‘outcomes’’: pre-test meeting, pre-test counseling, consent,
confidentiality, satisfaction with the person-to-person interac-
tions, post-test meeting to receive results, post-test counseling,
and referral to care.
They found that across countries and different facilities,
the majority of participants reported having received most of
the testing-related services. More than 90% reported having
a pre-test meeting, and around 80% were satisfied with the
personal interactions, with the consent process, and with
confidentiality. About 50% of participants reported receiving
all post-test services, and 71% of those who had tested
positive for HIV reported appropriate referral to care.
When they looked for differences between different
modes of testing, the researchers found that while they
existed, they did not consistently favor one mode over
another. Some outcomes scored higher in VCT facilities,
some in PMTCT facilities, and some in integrated facilities.
What Do These Findings Mean? While there is room for
improvement in HIV testing services (especially post-test
services) across the countries and facilities included, the
study did not reveal major problems with consent or
confidentiality. The results also suggest that services at
PMTCT and integrated facilities are not any worse than those
at VCT-only sites. It seems therefore reasonable to continue
expanding access to HIV testing and to include all facilities in
the scale-up. That said, this is only one of a number of
studies examining issues surrounding HIV testing, and
decisions should be based on all available evidence. The
results here are consistent with some of the other studies,
but there are also reports that counseling might become
neglected as testing is scaled up, and that offering testing
routinely at every doctor’s visit makes it seem mandatory
even if there is the possibility to ‘‘opt out.’’ Other analyses of
the MATCH study use in-depth interviews to understand in
more detail the feelings, experiences, and attitudes of
participants who have been tested as well as those who
have not been tested. It will be important to see whether
their results are consistent with the ones here, which are
based on a survey of people who have been tested.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001329.
N WHO has published a toolkit for scaling up HIV testing and
counseling services in resource-limited settings, as well as
the report Service Delivery Approaches to HIV Testing and
Counselling (HSC): A Strategic HTC Programme Framework
N In response to reactions to the 2007 joint WHO/UNAIDS
guidelines Guidance on Provider-Initiated HIV Testing and
Counselling in Health Facilities, the UNAIDS Reference
Group on HIV and Human Rights issued a Statement and
Recommendations on Scaling up HIV Testing and
Counselling
N The NAM/aidsmap website has a section on HIV testing
policies and guidelines.
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